Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Fingolimod

Copy Product Info
😃Good
Catalog No. T7939Cas No. 162359-55-9
Alias FTY-720A, FTY-720

Fingolimod (FTY-720A) is an antagonist of sphingosine 1-phosphate (S1P) (IC50 of 0.033 nM in K562 and NK cells).

Fingolimod

Fingolimod

Copy Product Info
😃Good
Purity: 99.6%
Catalog No. T7939Alias FTY-720A, FTY-720Cas No. 162359-55-9
Fingolimod (FTY-720A) is an antagonist of sphingosine 1-phosphate (S1P) (IC50 of 0.033 nM in K562 and NK cells).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$30In StockIn Stock
50 mg$37In StockIn Stock
100 mg$50In StockIn Stock
500 mg$126In Stock-
1 g$158InquiryInquiry
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.6%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Fingolimod (FTY-720A) is an antagonist of sphingosine 1-phosphate (S1P) (IC50 of 0.033 nM in K562 and NK cells).
Targets&IC50
S1P1:0.033 nM
In vitro
Fingolimod has been reported to reduce LPA synthesis via inhibition of the lysophospholipase autotaxin.?Fingolimod treatment correlates with a significant elevation of axonal cAMP, a crucial factor for axonal outgrowth.?Additionally, Fingolimod significantly reduces LPA levels in the injured nerve.?PF-8380 treatment correlates with improved myelin thickness[1]
Cell Research
Sciatic nerve crush was performed in wildtype C57BL/6, in immunodeficient Rag1 (-/-) and Foxn1 (-/-) mice.?Analyses were based on walking track analysis and electrophysiology, histology, and cAMP formation.?Quantification of different LPA species was performed by liquid chromatography coupled to tandem mass spectrometry.?Furthermore, functional consequences of autotaxin inhibition by the specific inhibitor PF-8380 and the impact of fingolimod on early cytokine release in the injured sciatic nerve were investigated[1].
SynonymsFTY-720A, FTY-720
Chemical Properties
Molecular Weight307.47
FormulaC19H33NO2
Cas No.162359-55-9
SmilesCCCCCCCCc1ccc(CCC(N)(CO)CO)cc1
Relative Density.1.016 g/cm3
Storage & Solubility Information
Storagekeep away from direct sunlight,store at low temperature,store under nitrogen | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Methanol: 30 mg/mL (97.57 mM), Sonication is recommended.
Ethanol: 7.69 mg/mL (25.01 mM), Sonication is recommended.
DMSO: 1 mg/mL (3.25 mM), Sonication is recommended.
Solution Preparation Table
DMSO/Ethanol/Methanol
1mg5mg10mg50mg
1 mM3.2523 mL16.2617 mL32.5235 mL162.6175 mL
Ethanol/Methanol
1mg5mg10mg50mg
5 mM0.6505 mL3.2523 mL6.5047 mL32.5235 mL
10 mM0.3252 mL1.6262 mL3.2523 mL16.2617 mL
20 mM0.1626 mL0.8131 mL1.6262 mL8.1309 mL
Methanol
1mg5mg10mg50mg
50 mM0.0650 mL0.3252 mL0.6505 mL3.2523 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Fingolimod | purchase Fingolimod | Fingolimod cost | order Fingolimod | Fingolimod chemical structure | Fingolimod in vitro | Fingolimod formula | Fingolimod molecular weight